Deal Snapshot
VeriSIM Life Acquires Spanish Drug Discovery Firm Molomics Biotech
Thursday 12 May 2022

US-based drug discovery and development technology company VeriSIM Life the leading Artificial Intelligence -enabled, unique R and D decisions de-risker for breakthrough drug development, has acquired Spanish drug discovery company Molomics Biotech, the company said.

Molomics Biotech leverages proprietary AI technology in an effort to design more efficacious and safer therapeutics to achieve higher successes in clinical trials.

Date Published: 12/05/2022